Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; Department of Laboratory Medicine, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.
Department of Laboratory Medicine, The Third Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; Department of Laboratory Medicine, Xiangya School of Medicine, Central South University, Changsha, Hunan, People's Republic of China.
Life Sci. 2023 Dec 1;334:122223. doi: 10.1016/j.lfs.2023.122223. Epub 2023 Oct 29.
Mitochondria serve as sites for energy production and are essential for regulating various forms of cell death induced by metal metabolism, targeted anticancer drugs, radiotherapy and immunotherapy. Cuproptosis is an autonomous form of cell death that depends on copper (Cu) and mitochondrial metabolism. Although the recent discovery of cuproptosis highlights the significance of Cu and mitochondria, there is still a lack of biological evidence and experimental verification for the underlying mechanism. We provide an overview of how Cu and cuproptosis affect mitochondrial morphology and function. Through comparison with ferroptosis, similarities and differences in mitochondrial metabolism between cuproptosis and ferroptosis have been identified. These findings provide implications for further exploration of cuproptotic mechanisms. Furthermore, we explore the correlation between cuproptosis and immunotherapy or radiosensitivity. Ultimately, we emphasize the therapeutic potential of targeting cuproptosis as a novel approach for disease treatment.
线粒体是能量产生的场所,对于调节金属代谢、靶向抗癌药物、放疗和免疫治疗诱导的各种形式的细胞死亡至关重要。铜死亡是一种依赖于铜 (Cu) 和线粒体代谢的自主细胞死亡形式。尽管铜死亡的最近发现强调了 Cu 和线粒体的重要性,但对于其潜在机制仍然缺乏生物学证据和实验验证。我们提供了一个概述,介绍 Cu 和铜死亡如何影响线粒体形态和功能。通过与铁死亡进行比较,确定了铜死亡和铁死亡之间在线粒体代谢方面的相似性和差异。这些发现为进一步探索铜死亡机制提供了启示。此外,我们探讨了铜死亡与免疫治疗或放射敏感性之间的相关性。最终,我们强调了将铜死亡作为一种新的疾病治疗方法的治疗潜力。
Life Sci. 2023-12-1
Biomed Pharmacother. 2024-2
Immunol Rev. 2024-1
Signal Transduct Target Ther. 2022-11-23
Zhong Nan Da Xue Xue Bao Yi Xue Ban.
Trends Pharmacol Sci. 2023-9
Naunyn Schmiedebergs Arch Pharmacol. 2025-8-12
Biometals. 2025-7-28
MedComm (2020). 2025-7-23
Front Immunol. 2025-6-30
Front Immunol. 2025-6-16
Discov Oncol. 2025-6-10
Int J Mol Med. 2025-8
J Inflamm Res. 2025-5-22
Front Pharmacol. 2025-5-8